HHS Restores Agency’s Premarket Review of LDTs by Glenn S. Demby | Dec 3, 2021 | Articles, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register
Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs) by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, Coronavirus, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs) by Glenn S. Demby | Nov 24, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies... This content is for Paid Members only.Login Register
FDA Imposes New Limits on COVID-19 Tests with Access to EUA Pathway by Glenn S. Demby | Nov 24, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.Login Register
CMS Repeals Rule Providing Expedited Medicare Coverage for MCIT “Breakthrough” Devices by Glenn S. Demby | Nov 19, 2021 | Articles, CMS-nir, Essential, Must read, National Lab Reporter... This content is for Paid Members only.Login Register